ACKR3 and posterior cortical atrophy: To evaluate the percentage of tumors with high CXCR7 expression at varying stages of PCa progression, we analyzed CXCR7 IHC staining intensity in primary tumors (n = 30), CRPC (n = 131, using samples from Li et al. (20) and the current study), and NEPC (n = 8).